Partner Headlines - IRWD

  1. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus
  2. Benzinga's Top Initiations

    Benzinga
  3. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga
  4. Allergan Acquires Rights to Ironwood's CONSTELLA from Almirall ...

    Benzinga
  5. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus
  6. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for ...

    Benzinga
  7. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line ...

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. Sucampo Stock Rebounds As Drug Gets Fast-Track Review

    IBD
  10. The World's Top 10 Financial Bloggers

    GuruFocus
  11. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  12. Ironwood Presents IW-9179 Phase IIa Data At American College ...

    Benzinga
  13. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD
  14. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga
  15. Benzinga's Top Downgrades

    Benzinga
  16. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  17. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  18. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  19. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  20. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  21. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  22. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  23. Stocks Hitting 52-Week Lows

    Benzinga
  24. Earnings Scheduled For January 15, 2013

    Benzinga
  25. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  26. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  27. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  28. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  29. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  30. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  31. Biotechs With Upcoming PDUFA Dates

    Benzinga
  32. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  33. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  34. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  35. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  36. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  37. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  38. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center